PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28433708-4	2017	They represent, as diacetyl prodrugs, AHR-active metabolites of the drug compounds laquinimod and tasquinimod, respectively, which are intended for the treatment of autoimmune diseases and cancer.	laquinimod	83-93	aryl hydrocarbon receptor	Rattus norvegicus	38-41	
30893768-4	2019	Clinical trials on LAQ have not reported any significant toxic outcomes and C2 has shown low toxicity in rats; however, their functional resemblance to the highly toxic AHR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) raises questions.	laquinimod	19-22	aryl hydrocarbon receptor	Rattus norvegicus	169-172